Additionally, our subgroup analyses revealed that patients with pretreatment anaemia, neoadjuvant anaemia or adjuvant anaemia had poorer survival outcomes when Hb concentration decreased more than 7.6 g/L from their initial Hb concentrations. The gene discussed is GSTM1; the disease is anemia (phenotype).